Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).
Reni M, Cereda S, Rognone A, Belli C, Ghidini M, Longoni S, Fugazza C, Rezzonico S, Passoni P, Slim N, Balzano G, Nicoletti R, Cappio S, Doglioni C, Villa E. Reni M, et al. Among authors: belli c. Cancer Chemother Pharmacol. 2012 Jan;69(1):115-23. doi: 10.1007/s00280-011-1680-2. Epub 2011 May 28. Cancer Chemother Pharmacol. 2012. PMID: 21626049 Clinical Trial.
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies.
Giovannini M, Gregorc V, Belli C, Roca E, Lazzari C, Viganò MG, Serafico A, Villa E. Giovannini M, et al. Among authors: belli c. J Oncol. 2009;2009:849051. doi: 10.1155/2009/849051. Epub 2009 Jun 22. J Oncol. 2009. PMID: 19584908 Free PMC article.
Antiangiogenic strategies in breast cancer management.
Giovannini M, Aldrighetti D, Zucchinelli P, Belli C, Villa E. Giovannini M, et al. Among authors: belli c. Crit Rev Oncol Hematol. 2010 Oct;76(1):13-35. doi: 10.1016/j.critrevonc.2009.12.004. Epub 2010 Aug 11. Crit Rev Oncol Hematol. 2010. PMID: 20702105 Review.
XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer.
Cereda S, Reni M, Rognone A, Ghidini M, Belli C, Longoni S, Fugazza C, Brioschi M, Nicoletti R, Balzano G, Passoni P, Villa E. Cereda S, et al. Among authors: belli c. Anticancer Res. 2010 Nov;30(11):4785-90. Anticancer Res. 2010. PMID: 21115942
Role of taxanes in pancreatic cancer.
Belli C, Cereda S, Reni M. Belli C, et al. World J Gastroenterol. 2012 Sep 7;18(33):4457-65. doi: 10.3748/wjg.v18.i33.4457. World J Gastroenterol. 2012. PMID: 22969215 Free PMC article.
208 results